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Abstract
Background: Non-invasive ventilation (NIV) may be useful after extubation in children. Our objective was to determine 
postextubation NIV characteristics and to identify risk factors of postextubation NIV failure.
Methods: A prospective observational study was conducted in an 8-bed pediatric intensive care unit (PICU). Following 
PICU protocol, NIV was applied to patients who had been mechanically ventilated for over 12 hours considered at high-
risk of extubation failure -elective NIV (eNIV), immediately after extubation- or those who developed respiratory failure 
within 48 hours after extubation -rescue NIV (rNIV)-. Patients were categorized in subgroups according to their main 
underlying conditions. NIV was deemed successful when reintubation was avoided. Logistic regression analysis was 
performed in order to identify predictors of NIV failure.
Results: There were 41 episodes (rNIV in 20 episodes). Success rate was 50% in rNIV and 81% in eNIV (p = 0.037). We 
found significant differences in univariate analysis between success and failure groups in respiratory rate (RR) decrease 
at 6 hours, FiO2 at 1 hour and PO2/FiO2 ratio at 6 hours. Neurologic condition was found to be associated with NIV 
failure. Multiple logistic regression analysis identified no variable as independent NIV outcome predictor.
Conclusions: Our data suggest that postextubation NIV seems to be useful in avoiding reintubation in high-risk 
children when applied immediately after extubation. NIV was more likely to fail when ARF has already developed (rNIV), 
when RR at 6 hours did not decrease and if oxygen requirements increased. Neurologic patients seem to be at higher 
risk of reintubation despite NIV use.
Background
Conventional mechanical ventilation (CMV) is a core fea-
ture of intensive care. Weaning and removement of endo-
tracheal tube are crucial processes, which often account
for a considerable part of CMV total time. Unsuccessful
extubation has been noted to be associated with an
increase of both morbidity and mortality in adult and
paediatric patients [1-4]. The documented rate of failed
extubations ranges from 4.1 to 14% in paediatric intensive
care units (PICUs) [1,2,5]. Therefore, strategies prevent-
ing the need for reintubation are needed.
Non invasive ventilation (NIV) has been proposed as a
useful therapy to wean patients after unsuccessful wean-
ing trials and to avoid reintubation in adults [6-10],
though controversy exists at this concern [11,12]. This
technique is increasingly being used in paediatric patients
over the last years [13-20]. Some of these studies have
included children receiving NIV because of ARF second-
ary to multiple causes including postextubation cases
[13,14]. Other authors, however, excluded from the anal-
ysis postextubation NIV use [15-17] in accordance with
NIV studies in adult patients and very low birth infants,
which analyze postextubation NIV separately [6,8-10,21-
23]. The reason provided to exclude these cases is that
NIV characteristics are very different when applied after
receiving CMV.
The objective of the present study was to determine
postextubation NIV characteristics and to identify risk
factors of postextubation NIV failure in children.
Methods
A prospective observational study was conducted in our
8-bed paediatric intensive care unit (PICU) from July
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2004 to December 2008 following NIV PICU protocol. To
be enrolled, patients had to have undergone CMV for
over 12 hours, to have adequate consciousness level
(Glasgow coma score of greater than or equal to 10), to
require no inotropics (or a maximum of 5 mcg/kg/minute
of dopamine) and to fulfill NIV inclusion criteria, listed
below. Extubation was performed following our internal
PICU protocol for weaning: FiO2 of less than or equal to
0.4 to maintain transcutaneous oxygen saturation >94%
(or baseline values in cyanotic cardiopathies), positive
end-expiratory pressure (PEEP) under 8 cm H2O and a
pressure support of under 12 cm H2O. An exception was
made to this protocol: PEEP could be ≥ 8 cmH2O in chil-
dren in whom an early extubation was considered benefi-
cial due to high risk of associated-ventilator pneumonia
(e.g. immunodeficiency). Sedation was progressively low-
ered according to our sedation protocol in order to avoid
withdrawal syndrome.
Types of postextubation NIV were elective NIV (eNIV)
when the patient was extubated directly to NIV, or rescue
NIV (rNIV) when the child developed ARF within 48
hours after extubation.
Inclusion criteria
• eNIV: children deemed at high-risk of extubation
failure (e.g. severe kyphoescholiosis, severe neuro-
m u s c u l a r  d i s o r d e r s )  o r  p a t i e n t s  e x t u b a t e d  f r o m  a
PEEP ≥ 8 cmH2O.
• rNIV: ARF within 48 hours after extubation which
did not respond to aggressive medical treatment and:
a respiratory rate above 2 standard deviations (SD) for
child's age normal range, or a partial pressure of arte-
rial oxygen to the fraction of inspired oxygen (PaO2:
FiO2) ratio under 250 and above 150 or a transcutane-
ous oxygen saturation <90% despite FiO2 of 50%, or
venous PCO2  > 55 mmHg or arterial PCO2  > 50
mmHg.
Criteria for reintubation
NIV was stopped and patients were intubated when oxy-
gen saturation was below 90% or venous PCO2 above 65
mmHg despite maximal NIV setting, or if management of
secretions was inadequate, or if patency of airways could
not be maintained, or when any of the exclusion criteria
appeared.
Exclusion criteria
cardiorespiratory arrest, hemodynamic instability despite
fluid load and vasoactive treatment, absence of cough
reflex, Glasgow coma score lower than 10, vocal cords
palsy, bullous neumopathy, pneumothorax and upper
gastrointestinal tract active bleeding.
Underlying condition
Patients were categorized in different subgroups accord-
ing to their main underlying conditions before they were
extubated. Each child could be classified in more than
one subgroup. Neurologic: children with severe enceph-
alopathy or severe neuromuscular disease; Respiratory:
patients intubated due to pneumonia, asthma, bronchi-
olitis or with underlying bronchopulmonary dysplasia;
Immunosupression; Cardiac: congenital cardiopathy;
Severe scoliosis.
Monitoring
All patients were continuously monitored by means of
electrocardiography, pulse oximeter and respiratory rate.
Blood gas analysis was only performed when considered
necessary by the attending physician.
NIV technique
CPAP or pressure support ventilation was delivered using
a nasal mask, face mask, or helmet device. The interface
was chosen according to child's age and size achieving
comfortability and avoiding air leaks. When using a
mask, initially it was applied manually onto the patient's
face, and then it was held by a paediatric head cap. Col-
loid dressings were placed on the major pressure points
to minimize skin injury. A heated humidifier (Fisher and
Paykel Healthcare, Auckland, New Zealand) was used in
all cases. Ventilators employed were BiPAP Vision
(Respironics, Pittsburgh, PA) for pressure support NIV
and CF 800 (Dräger, Lübeck, Germany) for CPAP.
Ventilation strategy
In eNIV, continuous positive airway pressure (CPAP) or
expiratory positive airway pressure (EPAP) was set at 1-2
cmH2O higher than previous PEEP during CMV. In rNIV,
CPAP or EPAP initial ventilator setting was 4-5 cmH2O.
In both types of postextubation NIV, inspiratory positive
airway pressure (IPAP) was started at 6-8 cmH2O. IPAP
was increased if the attending physician considered that
inspiratory volume was low according to auscultation and
thoracic motion, and if hypercarbia increased or did not
decrease. CPAP or EPAP were increased if no improve-
ment of pulse-oximetry O2 saturation or arterial PO2 was
achieved. If clinical situation did not improve with CPAP
and a good-fitting mask was available, the child could be
switched to pressure support NIV according to the
attending physician's decision.
Data collection
Patients with multiple NIV episodes were considered
individually, since each episode requiring NIV presents
new variables potentially affecting outcome. For each epi-
sode, the following variables were collected: age, gender,
weight, PICU stay, primary cause of intubation, underly-Mayordomo-Colunga et al. BMC Pediatrics 2010, 10:29
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ing disease, type of postextubation NIV, paediatric risk of
mortality (PRISM) score within 24 hours of admission,
type of interface, NIV duration, NIV outcome, mortality
and causes of death. Clinical data collected were respira-
tory rate (RR), heart rate (HR) and FiO2 before NIV was
started. The same data and CPAP, EPAP and IPAP were
collected at 1, 6, 12, 24 and 48 hours.
Outcome
NIV was considered successful when reintubation was
avoided.
Statistical analysis
Mean, median, standard deviation and range were used
to describe the sample. Quantitative continuous variables
were compared between groups using Mann Whitney's
non parametric tests if the variable had a non-normal dis-
tribution or unpaired Student's t test if the variable had a
normal distribution. Qualitative variables were compared
by Chi-square test (χ2). A logistic regression analysis was
performed in order to identify possible predictors of NIV
failure. Kaplan-Meier estimate-of-survival curve was
used to determine the cumulative risk of avoiding reintu-
bation. Multiple logistic regression analysis was per-
formed before NIV start and after 1, 6 and 12 hours.
Variables included in the multivariate analysis were those
which had a p value under 0.2 between success and failure
groups and also those variables which were considered
clinically important in order to control statistical confu-
sion. Variables included in the model were age, weight,
gender, HR difference to initial HR, RR difference to ini-
tial RR, FiO2, neurologic condition, type of postextuba-
tion NIV. At the first hour, IPAP was also included. Before
NIV was started, RR and HR were also included, instead
of HR or RR difference. PO2/FiO2 ratio, PCO2 and pH
were excluded from multivariate analysis due to the lack
of data. A p value < 0.05 was considered statistically sig-
nificant.
This research project was approved by the Research
Ethics Committee of the Hospital Universitario Central
de Asturias. Written informed consent was obtained
from patients' parents or guardians.
Results
During the study period, there were 1255 admissions in
our PICU. Two hundred and thirty-eight children
received CMV. Of these, 45 episodes received postextu-
bation NIV . Three of them were excluded because they
received CPAP by means of a different flow system venti-
lator (Infant Flow™ system). Another episode was also
excluded because inclusion criteria were not fulfilled.
Among those resulting 41 episodes (36 patients), 20 of
them belonged to rNIV group. CP AP was only used in
two cases (one failed after switching to pressure support
NIV). Baseline characteristics are shown in Table 1.
NIV was successful in 65.9% of cases. Baseline charac-
teristics of success and failure groups are shown in Table
2. Rate of success was significantly different between
rNIV and eNIV groups (50% vs 81%; p = 0.037). Figure 1
shows cumulative probability of avoiding reintubation
related to rNIV and eNIV groups. In 3 episodes, extuba-
tion was performed from a PEEP over 8 cmH2O and
eNIV was applied. None of these 3 cases failed NIV trial.
Causes of NIV failure were upper airway obstruction in
5 cases, apnoeas in 3 children, hypercapnia in 2, and
hemodynamic instability, hypoxemia, inability to manage
secretions and massive atelectasis in 1 episode each.
Median period between NIV beginning and reintubation
was 4.5 hours (range 0.2 - 19 hours). Mean stay was 19.0 ±
17.7 days in success group vs. 45.3 ± 39.3 days in failure
group (p = 0.001). Facial mask was used in 30 cases (13 in
rNIV), nasal mask in 5 (3 in rNIV), full-face mask in 2 (1
in rNIV) and helmet in 2 (both in rNIV). Median NIV
duration was 12 hours (range 0.2 - 149 hours). Two
deaths occurred during the study, both children belong-
ing to failure group. None of these deaths was related to
NIV use or to NIV failure.
Table 3 shows clinical variables with statistically signifi-
cant differences in univariate analysis between success
and failure groups. FiO2 at 1 hour was found to have an
area under the curve (AUC) of 0.836 to detect NIV fail-
ure. A FiO2 of 50% at 1 hour could predict NIV failure
with a sensitivity of 76.9% and specifity of 81.5%. RR
decrease at 6 hours had an AUC of 0.764 to predict NIV
success. A decrease of RR at 6 hours equal to or higher
than 4 bpm could predict NIV success with a sensitivity
of 92.3% and specifity of 57.1%.
Multiple logistic regression analysis revealed that no
variable included in the model was an independent pre-
dictive factor of postextubation NIV success or failure.
Discussion
Data about postextubation NIV use in children are
scarce. We conducted the present study following an
observational design, as patients' management was based
on our standard clinical practice criteria. To our knowl-
edge, this is the first study to identify predictive factors of
postextubation NIV outcome in a multidisciplinary
PICU. Previous pediatric studies about NIV use after
extubation focus on post-cardiac surgery patients [18,24].
Postextubation NIV can be used in three ways: (1) as an
adjunct to weaning patients from CMV by early extuba-
tion directly to NIV, (2) as a preventive application of NIV
to higher-risk patients who were extubated at the time
they fulfilled standard extubation criteria, or (3) as a
curative or rescue application of NIV to patients whoMayordomo-Colunga et al. BMC Pediatrics 2010, 10:29
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develop ARF after having been extubated according to
standard criteria. The first two indications represent chil-
dren included in our study as eNIV cases. The third indi-
cation corresponds to rNIV group.
Rate of success (65.9%) was lower than rates reported in
other NIV pediatric studies which do not include postex-
tubation cases [15,17]. A very similar success rate was
r e p o r t e d  b y  E s s o u r i  i n  t h e  s u b g r o u p  o f  p a t i e n t s  w i t h
respiratory failure after extubation [13] and by Pons in
children after cardiac surgery [18]. This suggests that
these patients must be even more carefully monitored
than those with no previous CMV. Furthermore, a
remarkable observation from our study was that all cases
which required reintubation failed NIV trial in the first
hours (Figure 1). Therefore, identification of early risk
factors for NIV failure is very important in order to avoid
an urgent or delayed reintubation, which seems to be
associated with higher mortality in adult patients with
extubation failure [25]. Conversely, if reintubation is
avoided in the first 12 hours after extubation, NIV is likely
to be successful.
We found that children developing ARF after extuba-
tion non-respondent to conventional medical therapy
(rNIV) were more likely to fail NIV support than those
extubated directly to NIV (eNIV). This goes in accor-
dance with previous studies in adult patients. Keenan and
Esteban found no outcome improvement in patients
treated with NIV who developed ARF in the following 48
h after extubation when compared with standard medical
therapy [8,9]. Trevisan reported the effectiveness of NIV
after unsuccessful weaning trials when applied directly
after extubation [6] and Nava described a lower rate of
reintubation in a population considered at risk of devel-
oping postextubation respiratory failure in NIV group in
comparison with standard medical therapy [7]. By con-
trast, our results suggest that eNIV and rNIV might be
considered as two different populations regarding NIV
management and effectiveness. It should be outlined that
Table 1: Baseline characteristics of the sample.
Whole sample (N = 41) Elective NIV (N = 21) Rescue NIV (N = 20) P value
Patients' characteristics
Age (months) 20.9 (0.5-206.8) 15.8(0.5-195.4) 44.5 (0.8-206.8) 0.160
Males (%) 63.4 52.4 75.0 0.133
Weight (kg) 17.9 ± 16.5 13.9 ± 12.8 22.0 ± 19.1 0.124
PRISM score 11.2 ± 7.3 8.9 ± 6.4 13.6 ± 7.5 0.038
CMV duration (hours) 139.2 ± 98.4 139.9 ± 112.8 137.7 ± 81.6 0.946
HR (beats/min) 131.6 ± 30.4 129.0 ± 27.1 134.4 ± 34.0 0.580
RR (breaths/min) 32.6 ± 13.7 31.3 ± 11.7 34.1 ± 15.8 0.524
FiO2 (%) 36.4 ± 13.3 38.2 ± 17.1 34.5 ± 7.5 0.375
PCO2 (mmHg) 52.5 ± 11.2 51.4 ± 7.3 53.6 ± 13.3 0.600
PO2/FiO2 ratio 336.1 ± 146.7 291.9 ± 136.5 350.1 ± 163.1 0.614
pH 7.36 ± 0.11 7.41 ± 0.02 7.35 ± 0.12 0.525
Underlying conditions - no
None 9 6 3
Neurologic 14 6 8
Respiratory 21 14 7
Immunosupression 3 2 1
Cardiac 1 1 0
Severe scoliosis 5 1 4
P value refers to the differences between elective and rescue NIV groups. Parameters are expressed in mean ± standard deviation except for 
age and CMV duration (median and range) and gender (%). Note that the addition of patients with underlying conditions exceeds the total 
number of patients because each patient might be included in different subgroups (see Methods section).NIV: non invasive ventilation; 
PRISM: paediatric risk of mortality (score); CMV: conventional mechanical ventilation; HR: heart rate; RR: respiratory rate; FiO2: fraction of 
inspired oxygen; PCO2: arterial partial pressure of oxygen dioxide; PO2: arterial partial pressure of oxygen.Mayordomo-Colunga et al. BMC Pediatrics 2010, 10:29
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some patients in eNIV group might have avoided intuba-
tion without using NIV, but NIV's potential secondary
effects are mild and NIV seems to be beneficial after
extubation [18,24].
Patients with underlying neurologic conditions were
found to be at higher risk for reintubation. Kurachek et al.
reported the same patient feature associated with extuba-
tion failure [1]. Similar finding have been made in adult
patients [26], and some reasons provided to explain this
fact are pharyngeal hypotonia and diminished cough
strenght and secretions clearance in these patients [1,26].
Evolution of RR in the first hours was described as an
outcome predictor in several paediatric studies [13,15].
The other clinical variable identified as a risk factor in the
current study was an increase in oxygen requirements.
This outcome predictor has been already reported in
patients with no previous CMV [15,16]. Also arterial
PO2/FiO2 was significantly higher in success group in the
first hour, which goes in accordance with other works in
hypoxemic patients [17].
Some limitations of this study must be outlined. First,
the power of the study is limited due to the sample size,
which obligates us to take our results with caution. Sec-
ond, it is not a randomized trial, which would be defini-
tive to draw conclusions. Taking into account that
postextubation NIV seems to be beneficial [24], perform-
ing such study could be problematic. Third, due to the
fact of being an observational study , blood gas analysis
w e r e  p e r f o r m e d  o n l y  i f  c o n s i d e r e d  n e c e s s a r y  b y  t h e
attending physician. Lastly, different interfaces were used,
Figure 1 Kaplan-Meier estimate-of-survival curve comparing the cumulative risk of avoiding reintubation regarding types of postextuba-
tion non-invasive ventilation: rNIV in discontinuous line and eNIV in continuous line. NIV: non-invasive ventilation.Mayordomo-Colunga et al. BMC Pediatrics 2010, 10:29
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Table 2: Baseline characteristics of success and failure groups.
Success group (N = 27) Failure group (N = 14) P value
Patients' characteristics
Age (months) 30.4 (0.5 - 206.8) 11.5 (0.8 - 199.2) 0.947
Males (%) 56.0 78.6 0.096
Weight (kg) 17.4 ± 15.8 18.7 ± 18.4 0.811
PRISM score 10.5 ± 7.2 12.7 ± 7.5 0.360
HR (beats/min) 130.2 ± 30.4 134.3 ± 31.4 0.688
RR (breaths/min) 34.6 ± 14.9 28.4 ± 10.1 0.187
FiO2 (%) 36.0 ± 9.3 37.0 ± 19.1 0.823
PCO2 (mmHg) 54.6 ± 11.8 46.6 ± 3.4 0.177
PO2/FiO2 ratio 337.8 ± 168.1 284.8 ± 77.9 0.381
pH 7.35 ± 0.11 7.44 ± 0.05 0.259
Primary cause of intubation - no (%)
Postsurgery 8 (29.6) 3 (21.4)
Bronchiolitis 4 (14.8) 4 (28.6)
Pneumonia 5 (18.5) 1 (7.1)
Severe cranial trauma 1 (3.7) 2 (14.3)
ARDS 2 (7.4) 0 (0)
CPR 2 (7.4) 0 (0)
Central apneas 0 (0) 2 (14.3)
Upper airways respiratory infection 2 (7.4) 0 (0)
Others 3 (11.2) 2 (14.3)
Underlying conditions - no (%)
Neurologic 6 (22.2) 8 (57.1) 0.025
Respiratory 17 (63.0) 7 (50.0) 0.424
Immunosupression 3 (11.1) 0 (0.0) 0.539
Cardiac 0 (0) 1 (7.1) 0.341
Severe scoliosis 3 (11.1) 2 (14.3) 0.768
Type of postextubation
NIV - no (%)
0.037
Elective NIV 17 (81) 4 (19)
Rescue NIV 10 (50) 10 (50)
PRISM: paediatric risk of mortality (score); HR: heart rate; RR: respiratory rate; FiO2: fraction of inspired oxygen; PCO2: arterial partial pressure 
of oxygen dioxide; PO2: arterial partial pressure of oxygen; ARDS: acute respiratory distress syndrome; CPR: cardiopulmonary resuscitation; 
NIV: non invasive ventilation
but we consider that no NIV failure could be attributable
to this. However, it must be noted that incorrect interface
choosing might influence NIV \outcome.
T h i s  s t u d y  h a s  s e v e r a l  s t r e n g t h s .  F i r s t ,  i t  i s  t h e  f i r s t
study focusing on paediatric postextubation NIV out-
come predictors. Second, the current prospective study is
based on daily clinical practice, which may allow the find-
ings to be useful for clinical management of these chil-
dren. Furthermore, despite the observational design,
inclusion and reintubation criteria were well defined fol-
lowing our internal protocol.
Conclusions
In conclusion, our data suggest that postextubation NIV
seems to be useful in avoiding reintubation in high-risk
children when applied immediately after extubation. NIVMayordomo-Colunga et al. BMC Pediatrics 2010, 10:29
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was more likely to fail when ARF has already developed
(rNIV), when RR at 6 hours did not decrease and if oxy-
gen requirements increased. Neurologic patients seem to
be at higher risk of reintubation despite NIV use.
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